Results of a phase 2 study of pacritinib (SB1518), a JAK2/JAK2(V617F) inhibitor, in patients with myelofibrosis
骨髓纤维化
JAK2 V617F
鲁索利替尼
内科学
医学
骨髓
作者
Rami S. Komrokji,John F. Seymour,Andrew W. Roberts,Martha Wadleigh,Luen Bik To,Robyn M. Scherber,E Turba,Andrew Dorr,Joy Zhu,Lixia Wang,Tanya Granston,Mary S. Campbell,Ruben A. Mesa
出处
期刊:Blood [American Society of Hematology] 日期:2015-03-12卷期号:125 (17): 2649-2655被引量:114